Skip to main content

Peer Review reports

From: Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer

Original Submission
19 Nov 2024 Submitted Original manuscript
21 Nov 2024 Author responded Author comments - Peng Gong
26 Nov 2024 Author responded Author comments - Peng Gong
Resubmission - Version 2
21 Nov 2024 Submitted Manuscript version 2
16 Dec 2024 Reviewed Reviewer Report
17 Dec 2024 Reviewed Reviewer Report
10 Jan 2025 Reviewed Reviewer Report
19 Feb 2025 Author responded Author comments - Peng Gong
Resubmission - Version 3
19 Feb 2025 Submitted Manuscript version 3
23 Feb 2025 Reviewed Reviewer Report
23 Feb 2025 Reviewed Reviewer Report
6 Mar 2025 Reviewed Reviewer Report
21 Mar 2025 Author responded Author comments - Peng Gong
Resubmission - Version 4
21 Mar 2025 Submitted Manuscript version 4
31 Mar 2025 Author responded Author comments - Peng Gong
Resubmission - Version 5
31 Mar 2025 Submitted Manuscript version 5
2 Apr 2025 Author responded Author comments - Peng Gong
Resubmission - Version 6
2 Apr 2025 Submitted Manuscript version 6
5 Apr 2025 Author responded Author comments - Peng Gong
Resubmission - Version 7
5 Apr 2025 Submitted Manuscript version 7
Publishing
7 Apr 2025 Editorially accepted
22 Apr 2025 Article published 10.1186/s12885-025-14096-x

You can find further information about peer review here.

Back to article page